0000000001087939

AUTHOR

Kirstin Mittelstrass

showing 2 related works from this author

Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance

2010

Recent studies strongly support an association of the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 with nicotine dependence (ND). However, the precise genotype-phenotype relationship is still unknown. Clinical and epidemiological data on smoking behavior raise the possibility that the relevant gene variants may indirectly contribute to the development of ND by affecting cognitive performance in some smokers who consume nicotine for reasons of "cognition enhancement." Here, we tested seven single nucleotide polymorphisms (SNPs) rs684513, rs637137, rs16969968, rs578776, rs1051730, rs3743078, rs3813567 from the CHRNA5-CHRNA3-CHRNB4 gene cluster for association with ND, me…

AdultMaleRiskGenotypeGene ExpressionNerve Tissue ProteinsSingle-nucleotide polymorphismReceptors NicotinicBiologyBioinformaticsPolymorphism Single NucleotideNicotineCellular and Molecular NeuroscienceCognitionGene clustermedicineHumansGenetic Predisposition to DiseaseRNA MessengerRisk factorAlleleGenetic Association StudiesGenetics (clinical)AgedGeneticsChromosomes Human Pair 15Gene Expression ProfilingCHRNA5HaplotypeWechsler ScalesGenetic VariationCognitionTobacco Use DisorderMiddle AgedPsychiatry and Mental healthMultigene Familybiology.proteinFemalemedicine.drugAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.

2008

Exposure to nicotine during smoking causes a multitude of metabolic changes that are poorly understood. We quantified and analyzed 198 metabolites in 283 serum samples from the human cohort KORA (Cooperative Health Research in the Region of Augsburg). Multivariate analysis of metabolic profiles revealed that the group of smokers could be clearly differentiated from the groups of former smokers and non-smokers. Moreover, 23 lipid metabolites were identified as nicotine-dependent biomarkers. The levels of these biomarkers are all up-regulated in smokers compared to those in former and non-smokers, except for three acyl-alkyl-phosphatidylcholines (e.g. plasmalogens). Consistently significant r…

Nicotinemedicine.medical_specialtyPublic Health and Epidemiology/Environmental HealthMetabolitelcsh:MedicineBiologyPharmacologyCohort StudiesNicotinechemistry.chemical_compoundInternal medicineDiabetes and Endocrinology/EndocrinologyGene expressionmedicineMetabolomeCluster AnalysisHumansAlkylglycerone-phosphate synthaselcsh:Sciencechemistry.chemical_classificationAlkyl and Aryl TransferasesMultidisciplinarySmokinglcsh:RLipid metabolismPublic Health and Epidemiology/Global HealthChemical Biology/Small Molecule ChemistryEnzymeEndocrinologychemistryBiochemistry/Small Molecule ChemistryGlycerophospholipidMetabolomePhosphatidylcholineslcsh:Qbiology.geneMental Health/Personality DisordersBiomarkersResearch Articlemedicine.drugPLoS ONE
researchProduct